| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ABIOMED INC | 1,450,000 | 137,475,000 | 35.98% | ||
| 2 | REVANCE THERAPEUTICS INC COM | 4,592,047 | 80,177,000 | 20.98% | ||
| 3 | ENTELLUS MEDICAL INC | 3,813,197 | 69,362,000 | 18.15% | ||
| 4 | CORIUM INTERNATIONAL INC | 9,353,304 | 36,104,000 | 9.45% | ||
| 5 | AXOGEN INC | 4,861,111 | 26,056,000 | 6.82% | ||
| 6 | ENDOLOGIX INC | 1,257,468 | 16,776,000 | 4.39% | ||
| 7 | MEDICINOVA INC COM NEW | 1,170,370 | 8,591,000 | 2.25% | ||
| 8 | ACURA PHARMACEUTICALS INC | 1,956,397 | 5,537,000 | 1.45% | ||
| 9 | Catalyst Biosciences | 1,179,352 | 2,017,000 | 0.53% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-16-003244, filed 2016.05.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
